Long-Acting ART: Cabotegravir Plus Rilpivirine

In this episode, Ian Frank, MD, discusses long-acting HIV treatment with cabotegravir plus rilpivirine for people with HIV, including:

• Efficacy data with every-8-week dosing
• Real-world use in people with viremia 
• Initiation and continuation strategies
• Virologic failure data
• Safety information

 

Presenter:

Ian Frank, MD

Associate Chief

Division of Infectious Diseases

Professor of Medicine

University of Pennsylvania

Philadelphia, Pennsylvania

To download the slides: https://bit.ly/3HX1GGn

 

To view the full online program: https://bit.ly/3ZjSFhg

 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.